To verify the role of NEIL3 in therapeutic sensitivity, we constructed NEIL3 knockdown cell lines via transfecting two small interfering RNAs into lymph node carcinoma of the prostate (LNcap), Duke University 145 (DU145) and prostate cancer cell line (PC3) cells. The gene discussed is NEIL3; the disease is Familial prostate cancer.